Back
Humacyte Stock Predictions
Buy
63
HUMA
Humacyte
Last Price:
7.15
Seasonality Move:
-5.65%
7 Day Trial
ALL ACCESS PASS
$
7
Humacyte Stock Forecast
- Over the next 52 weeks, Humacyte has on average historically risen by 2.1% based on the past 3 years of stock performance.
- Humacyte has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Humacyte Stock Undervalued?
The current Humacyte [HUMA] share price is $7.15. The Score for HUMA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal. - HUMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Humacyte Stock Go Up Next Year?
- Over the next 52 weeks, Humacyte has on average historically risen by 2.1% based on the past 3 years of stock performance.
Humacyte Stock Rating
Buy
63
Humacyte (HUMA)
is a Buy
Is Humacyte overpriced?
- Humacyte has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Humacyte Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
humacyte.com
52-Week Data
52-Week High:
7.78
52-Week Low:
1.96
Prediction Charts
Market Cap:
851.45M
Price in USD:
7.15
Volume:
1.45M
Beta:
1.29
Technical Analysis
SMA50:
4.20
SMA100:
3.79
SMA200:
3.36
52-Wk Change:
82.4%
Stock Predictions
-
Is Humacyte stock public?
Yes, Humacyte is a publicly traded company. -
What is the Humacyte stock quote today?
The Humacyte stock price is 7.15 USD today. -
How to buy Humacyte stock online?
You can buy Humacyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-7 | 4.54 | 4.62 | 4.75 | 4.52 |
May-8 | 4.72 | 4.51 | 4.74 | 4.41 |
May-9 | 4.41 | 4.52 | 4.63 | 4.41 |
May-10 | 4.50 | 4.70 | 4.84 | 4.32 |
May-13 | 4.74 | 5.48 | 5.67 | 4.74 |
May-14 | 5.91 | 6.42 | 6.62 | 5.61 |
May-15 | 6.80 | 6.47 | 6.96 | 6.18 |
May-16 | 6.50 | 6.42 | 7.02 | 6.36 |
May-17 | 6.36 | 6.33 | 6.55 | 5.87 |
May-20 | 6.35 | 7.06 | 7.18 | 6.07 |
May-21 | 7.10 | 7.03 | 7.46 | 6.90 |
May-22 | 7.03 | 7.56 | 7.78 | 6.97 |
May-23 | 7.65 | 7.21 | 7.68 | 7.13 |
May-24 | 7.29 | 7.15 | 7.45 | 7.05 |
Humacyte Earnings
Humacyte Earnings Report: Per Share Humacyte Earnings Q1 Q2 Q3 and Q4 last year and next year.
Humacyte Forecast Revenue Growth
Humacyte Stock Analysis: Historical quarterly revenues per share for Humacyte and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.18 per share.
* Humacyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.